RECRUITING

Effect of Apollo Wearable on Long COVID-19 Symptoms.

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to examine how Apollo wearable use impacts symptoms and quality of life following long COVID.

Official Title

Effect of Apollo Wearable on Symptoms Related to Post-acute Sequelae SARS-CoV-2 Infection (PASC).

Quick Facts

Study Start:2023-10-23
Study Completion:2025-03
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06097442

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * New purchasers of Apollo who haven't started using their Apollo device or previous users of Apollo who haven't used Apollo in the preceding 14 days.
  2. * Age 18 years or over
  3. * Currently experiencing symptoms related to long-COVID according to PASC (self report).
  4. * Must be experiencing PASC symptoms in at least one of the following domains:
  1. * Inability to use or access a compatible Android or iOS smartphone
  2. * Are unable to complete consent and questionnaires written in English
  3. * Current resident of a European Union (EU) country

Contacts and Locations

Study Contact

Belinda Tan, MD, PhD
CONTACT
4129450345
belinda@theboardofmedicine.org
Ema Perez, BS
CONTACT
18559220057
clinical_coordinator@apolloneuro.com

Study Locations (Sites)

The Board of Medicine
Pittsburgh, Pennsylvania, 15219
United States

Collaborators and Investigators

Sponsor: The Board of Medicine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-10-23
Study Completion Date2025-03

Study Record Updates

Study Start Date2023-10-23
Study Completion Date2025-03

Terms related to this study

Keywords Provided by Researchers

  • long-COVID
  • Apollo

Additional Relevant MeSH Terms

  • Post-acute Sequelae of SARS-COV-2 Infection